Evolution of phage display: from bioactive peptides to bioselective nanomaterials.
BACKGROUND
New phage-derived biorecognition nanomaterials have emerged recently as a result of the in-depth study of the genetics and structure of filamentous phage and the evolution of phage display technology.


OBJECTIVE
This review focuses on the progress made in the development of these new nanomaterials and discusses the prospects of using phage as a bioselectable molecular recognition interface in medical and technical devices.


METHODS
The author used data obtained both in his research group and sourced using Science Citation Index (Web of Science) search resources.


CONCLUSIONS
The merging of phage display technologies with nanotechnology over the past few years has proved promising and has already shown its vitality and productivity by contributing vigorously to different areas of medicine and technology, such as medical diagnostics and monitoring, molecular imaging, targeted drug and gene delivery, vaccine development, as well as bone and tissue repair.
Petrenko
Va
V
Auburn University, Department of Pathobiology, AL 36849, USA. petreva@auburn.edu
D000818:Animals; D015374:Biosensing Techniques; D016503:Drug Delivery Systems; D055808:Drug Discovery; D018014:Gene Transfer Techniques; D049329:Nanostructures; D019151:Peptide Library; D010455:Peptides / Q000737:chemistry*
D019151:Peptide Library; D010455:Peptides